The effect of amisulpride on prolactin level and clinical efficacy in first-episode schizophrenic patients
10.3760/cma.j.issn.1674-6554.2015.01.011
- VernacularTitle:氨磺必利治疗首发精神分裂症的泌乳素水平与临床疗效分析
- Author:
Zhaoxi ZHONG
;
Luxian LYU
- Publication Type:Journal Article
- Keywords:
Amisulpride;
Schizophrenia;
Prolactin;
Case control study
- From:
Chinese Journal of Behavioral Medicine and Brain Science
2015;24(1):38-41
- CountryChina
- Language:Chinese
-
Abstract:
Objective To discuss the effect of amisulpride on the prolactin level in serum of first-episode schizophrenic patients and its relationship with symptoms.Methods 45 patients who met the DSM-IV schizophrenia diagnostic criteria and 45 age-and gender-matched healthy controls were assessed the clinical symptoms using positive and negative syndrome scale(PANSS) and pmlactin level in serum was detected using enzymelinked immunosorbent assay.Student's t test was used to compare the prolactin level before and after amisulpride treatment and correlation analysis was used to investigate the relationship between prolactin level in serum and symptoms with P＜0.05 were considered significantly different.Results There was significant increase in prolactin level in serum after amisulpride treatment in first-episode schizophrenic patients((12.52±8.85) ng/ml,(52.60±22.93 ng/ml,t=12.165,P＜0.001).There was a positive correlation between prolactin level in serum and reduction rate of negative symptoms (r=0.24,P＜0.05).Conclusion Amisulpride can increase prolactin level in serum;and the rise of serum prolactin is closely related to the improvement of negative symptoms.
